By Russell Logan in Shout About ME.
Though there are as yet no readily available, well-accepted, objective diagnostic tests for ME and CFS, work is ongoing in several key areas to develop one.
One objective measure, the 2-day CPET, is gaining acceptance and has been used with success in legal presentations. A drawback to this measure is its potential for harming patients.
And there are good subjective or self-reported diagnostic measures, though these are of limited value in clinical diagnosis.
In its response to the recent NIH solicitation for input into new research strategies for ME/CFS, the International Association for Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis (IACFS/ME) documented emerging opportunities, research needs, and continuing challenges, but in particular highlighted promising work on developing a diagostic test or biological marker for the illness.
To read the rest of this story, click on the link below: